Effect of CPAP vs. mandibular advancement device for excessive daytime sleepiness, fatigue, mood, sustained attention, and quality of life in patients with mild OSA

被引:8
|
作者
Luz, Gabriela Pontes [1 ]
Badke, Luciana [1 ]
Nery, Luiz Eduardo [1 ]
Silva, Luciana Oe [2 ]
Guimaraes, Thais Moura [2 ]
Coelho, Glaury [2 ]
Millani, Aline [2 ]
Alves, Rodrigo Gomes [2 ]
Kase, Camila [2 ]
Tufik, Sergio [2 ]
Bittencourt, Lia [2 ]
机构
[1] Univ Fed Sao Paulo, Dept Med, Disciplina Pneumol, Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, Dept Psicobiol, Disciplina Med & Biol Sono, Sao Paulo, Brazil
关键词
CPAP; Mandibular advancement device; Excessive daytime sleepiness; Sustained attention; Quality of life; Mild OSA; POSITIVE AIRWAY PRESSURE; ORAL APPLIANCE THERAPY; APNEA; VALIDATION; TRIAL; DISORDERS; EFFICACY; VERSION;
D O I
10.1007/s11325-022-02694-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective This study's objective was to compare the best long-term treatment, mandibular advancement device (MAD) or continuous positive airway pressure (CPAP), for patients with mild obstructive sleep apnea (OSA) in improving excessive daytime sleepiness, fatigue, mood, sustained attention, and quality of life. Methods This study was a single-blind, parallel, randomized clinical trial with controls. The sample was composed of individuals between 18 and 65 years of age with a body mass index of < 35 kg/m(2) and apnea/hypopnea index above five and less than 15. Participants were submitted to physical examination, polysomnography, and the following questionnaires: Pittsburgh Sleep Quality Index, Berlin Questionnaire, Epworth Sleepiness Scale, Stanford Sleepiness Scale, Karolinska Sleepiness Scale, Modified Fatigue Impact Scale, Functional Outcomes of Sleep Questionnaire, Beck Anxiety Inventory, and Beck Depression Inventory. They were also presented with the following tests: maintenance of wakefulness test and psychomotor vigilance task. Results Of 79 patients, 25 were in the MAD group, 31 in the CPAP group, and 23 in the control group. Polysomnographic parameters were best normalized with CPAP compared with MAD. Fatigue was improved in the MAD and CPAP groups, with no difference between these treatments. Quality of life was also improved with both treatments, but CPAP was superior to MAD. Daytime sleepiness, mood, and sustained attention showed no difference with the interventions. Greater adherence was obtained with MAD patients than with CPAP measured by hours of use. Conclusions Treatment with CPAP was better at normalizing polysomnographic parameters and improving quality of life in patients with mild OSA. Both treatments improved fatigue with no difference between the two treatments. Neither treatment improved daytime sleepiness, mood or sustained attention.
引用
收藏
页码:991 / 1003
页数:13
相关论文
共 19 条
  • [1] Effect of CPAP vs. mandibular advancement device for excessive daytime sleepiness, fatigue, mood, sustained attention, and quality of life in patients with mild OSA
    Gabriela Pontes Luz
    Luciana Badke
    Luiz Eduardo Nery
    Luciana Oe Silva
    Thais Moura Guimarães
    Glaury Coelho
    Aline Millani
    Rodrigo Gomes Alves
    Camila Kase
    Sergio Tufik
    Lia Bittencourt
    Sleep and Breathing, 2023, 27 : 991 - 1003
  • [2] The Effect of CPAP in Normalizing Daytime Sleepiness, Quality of Life, and Neurocognitive Function in Patients with Moderate to Severe OSA
    Antic, Nick A.
    Catcheside, Peter
    Buchan, Catherine
    Hensley, Michael
    Naughton, Matthew T.
    Rowland, Sharn
    Williamson, Bernadette
    Windler, Samantha
    McEvoy, R. Doug
    SLEEP, 2011, 34 (01) : 111 - 119
  • [3] Long-term effects of Mandibular Advancement Device on symptomatic control and quality of life in patients with OSA and CPAP intolerance
    Lago Lagunas, Laura
    Yong Portugal, Edwin
    Pozuelo Sanchez, Laura
    Parra Jarque, Maria
    Cano Pumarega, Irene
    Garcia Sanchez, Aldara
    Gallo Rivero, Valeria
    Pedrera-Mazarro, Antonio
    Gonzalez Rodriguez, Liliana
    Briceno Franquiz, Winnifer Yaralis
    Gonzalez Castro, Sara
    Jara Alonso, Ignacio
    Castillo Duran, Ana Victoria
    Carreno Alejandre, Alberto
    Velasco Martin, Juan Manuel
    Gomez-Barreda, Diego Ceballos
    Yanez Quintero, Maria Angelica
    Manas Baena, Eva Maria
    JOURNAL OF SLEEP RESEARCH, 2024, 33
  • [4] PREDICTORS OF EXCESSIVE DAYTIME SLEEPINESS AND QUALITY OF LIFE IN PATIENTS WITH REM AND NON-REM OSA
    Mokhlesi, B.
    Ghods, F.
    Knutson, K. L.
    SLEEP, 2010, 33 : A137 - A137
  • [5] CPAP PRESSURE IS ASSOCIATED WITH EFFECT OF MANDIBULAR ADVANCEMENT DEVICE FOR TREATING TREATMENT-NAIVE PATIENTS WITH OSA
    Lee, Chien-Feng
    Chen, Yunn-Jy
    Huang, Wen-Chi
    Hung, Yu-Jou
    Lee, Pei-Lin
    Yu, Chong-Jen
    RESPIROLOGY, 2018, 23 : 37 - 37
  • [6] Daytime Sleepiness and Quality of Life in Obstructive Sleep Apnoea Patients before and after Long-Term Mandibular Advancement Device Treatment
    Halfeld, Signe
    Sonnesen, Liselotte
    DENTISTRY JOURNAL, 2022, 10 (12)
  • [7] The treatment of mild OSA with CPAP or mandibular advancement device and the effect on blood pressure and endothelial function after one year of treatment
    Guimaraes, Thais Moura
    Poyares, Dalva
    e Silva, Luciana Oliveira
    Luz, Gabriela
    Coelho, Glaury
    Dal Fabbro, Cibele
    Tufik, Sergio
    Bittencourt, Lia
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2021, 17 (02): : 149 - 158
  • [8] The effect of CPAP therapy on excessive daytime sleepiness and quality of life in subjects with obstructive sleep apnoea: an AB design study
    Kavitha Venkatnarayan
    Uma Devaraj
    Chitra Veluthat
    Varghese Louis
    Priya Ramachandran
    George D’Souza
    Uma Maheswari Krishnaswamy
    Sleep and Breathing, 2021, 25 : 1351 - 1357
  • [9] The effect of CPAP therapy on excessive daytime sleepiness and quality of life in subjects with obstructive sleep apnoea: an AB design study
    Venkatnarayan, Kavitha
    Devaraj, Uma
    Veluthat, Chitra
    Louis, Varghese
    Ramachandran, Priya
    D'Souza, George
    Krishnaswamy, Uma Maheswari
    SLEEP AND BREATHING, 2021, 25 (03) : 1351 - 1357
  • [10] Impact on symptomatic control and quality of life in patients with OSA and CPAP intolerance treated with mandibular advancement device after 5 years of follow-up
    Lagunas, Laura Lago
    Portugal, Edwin Yong
    Baena, Eva Manas
    Pumarega, Irene Cano
    Sanchez, Aldara Garcia
    Sanchez, Laura Pozuelo
    Jarque, Maria Parra
    Alejandre, Alberto Carreno
    Castro, Sara Gonzalez
    Franquiz, Winnifer Yaralis Briceno
    Duran, Ana Victoria Castillo
    Jara, Ignacio
    Velasco, Juan Manuel
    Gomez-Barreda, Diego Ceballos
    Quintero, Maria Angelica Yanez
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64